Paradeep Phosphates Strong FY26 Performance Driven by Operational Efficiency

Paradeep Phosphates Ltd reported a strong financial year ending March 31, 2026, marked by significant growth across key metrics. The company achieved a 29% YoY increase in revenue to ₹21,826 crore and a 52% YoY surge in Profit After Tax (PAT) to ₹1,000 crore. These results underscore the firm’s operational resilience and successful execution of capacity expansion projects despite global market volatility and fluctuations in raw material pricing.

Fiscal Year 2026 Financial Highlights

Paradeep Phosphates demonstrated consistent growth throughout the fiscal year. The company reported revenue from operations of ₹21,826 crore, reflecting a 29% year-on-year increase. Profitability also saw significant expansion, with EBITDA rising 33% to ₹2,259 crore, and Profit After Tax (PAT) climbing 52% to ₹1,000 crore. For the final quarter (Q4 Jan-Mar 2026), the company generated a revenue of ₹4,702 crore with a PAT of ₹161 crore.

Operational Milestones and Expansion

The company achieved notable production success, reaching 3.67 MMTPA of fertilizer production and maintaining nearly 100% capacity utilization. Sales volume grew by 10%, driven largely by a 22% surge in NPK grade sales, which reached 24.64 LMT.

Strategic infrastructure improvements were a core focus in FY26. The company successfully commissioned new Sulphuric Acid plants at Paradeep (500,000 MTPA) and Mangalore (100,000 MTPA), expanding total capacity by 45%. Looking ahead, management confirmed that plans to double Phos acid capacity to 1 MMTPA are well underway, with the first phase expected to be commissioned in FY27.

Strategic Outlook and Sustainability

The leadership attributes this performance to supply chain efficiencies and deep distribution network capabilities covering 18 states. Committed to long-term value creation, the company has also focused on ESG initiatives, achieving an S&P Global ESG score of 76, placing it in the top 2 percentile within the global chemical sector. With an enhanced long-term credit rating of AA-(stable), the company remains positioned to optimize its finance costs while continuing to drive growth through innovation and manufacturing excellence.

Source: BSE

Previous Article

Dr. Reddy’s Laboratories Board Approves New Stock Option Grants for Employees